Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bieck

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Neuropsychobiology|January 1, 1996
Different modes of data processing and statistical testing applied to the same set of pharmaco-EEG recordings: effects on the evaluation of a selective and reversible MAO A inhibitor (brofaromine)I W Reimann, M Jobert, C H Gleiter, et al.
International Journal of Computer Assisted Radiology and Surgery|November 17, 2022
Keyword-augmented and semi-automatic generation of FESS reports: a proof-of-concept studyV Kunz, V Wildfeuer, R Bieck, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Role of cytochrome P4502D6 in the metabolism of brofaromine. A new selective MAO-A inhibitorN Feifel, K Kucher, L Fuchs, et al.
Neurochemical Research|November 1, 1993
Clinical pharmacology of the new COMT inhibitor CGP 28,014P R Bieck, K H Antonin, G Farger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 5, 2003
Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled studyStephan A Chalon, Luc-André Granier, François R Vandenhende, et al.
Circulation|June 9, 2004
Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profilesSimi Vincent, Peter R Bieck, Emily M Garland, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Neuropsychobiology|January 1, 1996
Different modes of data processing and statistical testing applied to the same set of pharmaco-EEG recordings: effects on the evaluation of a selective and reversible MAO A inhibitor (brofaromine)I W Reimann, M Jobert, C H Gleiter, et al.
International Journal of Computer Assisted Radiology and Surgery|November 17, 2022
Keyword-augmented and semi-automatic generation of FESS reports: a proof-of-concept studyV Kunz, V Wildfeuer, R Bieck, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Role of cytochrome P4502D6 in the metabolism of brofaromine. A new selective MAO-A inhibitorN Feifel, K Kucher, L Fuchs, et al.
Neurochemical Research|November 1, 1993
Clinical pharmacology of the new COMT inhibitor CGP 28,014P R Bieck, K H Antonin, G Farger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 5, 2003
Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled studyStephan A Chalon, Luc-André Granier, François R Vandenhende, et al.
Circulation|June 9, 2004
Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profilesSimi Vincent, Peter R Bieck, Emily M Garland, et al.
Pageof 4